UK skin health specialist SkinBioTherapeutics has developed a probiotic powder targeting psoriasis – a product that centres on exciting advances in the gut-skin axis and holds wider promise for industry, its CEO says.
The agricultural processing company has completed a clinical study, recently accepted for publication in the international peer-reviewed journal Acta Dermato-Venereologica (which covers the fields of dermatology and venereology) that shows ingestible...
Plant-based beauty and skin care brands seem to be cropping up everywhere; presumably because nature-based formulations that deliver results are in high demand. With 15 years of global business behind it, Kamedis hopes to meet that demand for US beauty...
We are constantly warned about the dangers of sun exposure and the importance of sun protection, but there are still some scenarios in which a little bit of sun, albeit in moderation, can be a good thing.
New research presented yesterday has revealed that a new class of
biologic drug may bring new relief to those suffering from the skin
condition psoriasis.
A UK dermatological study into the affects of a compound extracted
from Araroba trees claim they have improved the treatment for
psoriasis. Simon Pitman reports on what could prove to be a
break-through for a condition that affects...
![Addressing skin health concerns via the gut-skin axis is the future of the skin microbiome space, according to the executive [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2021/09/02/skinbiotherapeutics-axisbiotix-probiotic-powder-for-psoriasis-holds-wider-promise-says-ceo/12788748-1-eng-GB/SkinBioTherapeutics-AxisBiotix-probiotic-powder-for-psoriasis-holds-wider-promise-says-CEO.jpg)
